The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2024

Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2024

Publishing Date : Jan, 2024

License Type :

Report Code : 1791956

No of Pages : 78

Ask Your Query

Report Description
Table of Content

Synopsis

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The global Recombinant Human Erythropoietin (rhEPO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Recombinant Human Erythropoietin (rhEPO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant Human Erythropoietin (rhEPO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Recombinant Human Erythropoietin (rhEPO) include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Erythropoietin (rhEPO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Erythropoietin (rhEPO).

Report Scope

The Recombinant Human Erythropoietin (rhEPO) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Erythropoietin (rhEPO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Erythropoietin (rhEPO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma

Segment by Type

ESRD
Cancer
HIV
Wounds and Neural Disease

Segment by Application

Hospitals
Retail Pharmacies

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Netherlands)
Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Erythropoietin (rhEPO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Erythropoietin (rhEPO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Recombinant Human Erythropoietin (rhEPO) Market Overview
1.1 Product Overview and Scope of Recombinant Human Erythropoietin (rhEPO)
1.2 Recombinant Human Erythropoietin (rhEPO) Segment by Type
1.2.1 Global Recombinant Human Erythropoietin (rhEPO) Market Value Comparison by Type (2024-2030)
1.2.2 ESRD
1.2.3 Cancer
1.2.4 HIV
1.2.5 Wounds and Neural Disease
1.3 Recombinant Human Erythropoietin (rhEPO) Segment by Application
1.3.1 Global Recombinant Human Erythropoietin (rhEPO) Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.4 Global Recombinant Human Erythropoietin (rhEPO) Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue 2019-2030
1.4.2 Global Recombinant Human Erythropoietin (rhEPO) Sales 2019-2030
1.4.3 Global Recombinant Human Erythropoietin (rhEPO) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Erythropoietin (rhEPO) Market Competition by Manufacturers
2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Erythropoietin (rhEPO) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Erythropoietin (rhEPO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Erythropoietin (rhEPO), Product Type & Application
2.7 Recombinant Human Erythropoietin (rhEPO) Market Competitive Situation and Trends
2.7.1 Recombinant Human Erythropoietin (rhEPO) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Erythropoietin (rhEPO) Players Market Share by Revenue
2.7.3 Global Recombinant Human Erythropoietin (rhEPO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Erythropoietin (rhEPO) Retrospective Market Scenario by Region
3.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Erythropoietin (rhEPO) Global Recombinant Human Erythropoietin (rhEPO) Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales by Region: 2025-2030
3.3 Global Recombinant Human Erythropoietin (rhEPO) Global Recombinant Human Erythropoietin (rhEPO) Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Region: 2025-2030
3.4 North America Recombinant Human Erythropoietin (rhEPO) Market Facts & Figures by Country
3.4.1 North America Recombinant Human Erythropoietin (rhEPO) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Erythropoietin (rhEPO) Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Erythropoietin (rhEPO) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Recombinant Human Erythropoietin (rhEPO) Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Erythropoietin (rhEPO) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Erythropoietin (rhEPO) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Recombinant Human Erythropoietin (rhEPO) Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Erythropoietin (rhEPO) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Erythropoietin (rhEPO) Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Erythropoietin (rhEPO) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Erythropoietin (rhEPO) Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Erythropoietin (rhEPO) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Erythropoietin (rhEPO) Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Erythropoietin (rhEPO) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3SBio
6.1.1 3SBio Corporation Information
6.1.2 3SBio Description and Business Overview
6.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.1.5 3SBio Recent Developments/Updates
6.2 Shanghai Chemo
6.2.1 Shanghai Chemo Corporation Information
6.2.2 Shanghai Chemo Description and Business Overview
6.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.2.5 Shanghai Chemo Recent Developments/Updates
6.3 Chengdu Diao
6.3.1 Chengdu Diao Corporation Information
6.3.2 Chengdu Diao Description and Business Overview
6.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.3.5 Chengdu Diao Recent Developments/Updates
6.4 NCPC Genetech
6.4.1 NCPC Genetech Corporation Information
6.4.2 NCPC Genetech Description and Business Overview
6.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.4.5 NCPC Genetech Recent Developments/Updates
6.5 Kyowa Hakko Kirin
6.5.1 Kyowa Hakko Kirin Corporation Information
6.5.2 Kyowa Hakko Kirin Description and Business Overview
6.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.5.5 Kyowa Hakko Kirin Recent Developments/Updates
6.6 Shandong Kexing
6.6.1 Shandong Kexing Corporation Information
6.6.2 Shandong Kexing Description and Business Overview
6.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.6.5 Shandong Kexing Recent Developments/Updates
6.7 Ahua Pharmaceutical
6.6.1 Ahua Pharmaceutical Corporation Information
6.6.2 Ahua Pharmaceutical Description and Business Overview
6.6.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.7.5 Ahua Pharmaceutical Recent Developments/Updates
6.8 Biosidus
6.8.1 Biosidus Corporation Information
6.8.2 Biosidus Description and Business Overview
6.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.8.5 Biosidus Recent Developments/Updates
6.9 Dragon Pharma
6.9.1 Dragon Pharma Corporation Information
6.9.2 Dragon Pharma Description and Business Overview
6.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product Portfolio
6.9.5 Dragon Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Erythropoietin (rhEPO) Industry Chain Analysis
7.2 Recombinant Human Erythropoietin (rhEPO) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Erythropoietin (rhEPO) Production Mode & Process
7.4 Recombinant Human Erythropoietin (rhEPO) Sales and Marketing
7.4.1 Recombinant Human Erythropoietin (rhEPO) Sales Channels
7.4.2 Recombinant Human Erythropoietin (rhEPO) Distributors
7.5 Recombinant Human Erythropoietin (rhEPO) Customers
8 Recombinant Human Erythropoietin (rhEPO) Market Dynamics
8.1 Recombinant Human Erythropoietin (rhEPO) Industry Trends
8.2 Recombinant Human Erythropoietin (rhEPO) Market Drivers
8.3 Recombinant Human Erythropoietin (rhEPO) Market Challenges
8.4 Recombinant Human Erythropoietin (rhEPO) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}